[1]
Tyagi, R.; Verma, S.; Mishra, S.; Srivastava, M.; Alam, S.; Khan, F.; Srivastava, S.K. In Vitro and in silico studies of glycyrrhetinic acid derivatives as anti-filarial agents. Curr. Top. Med. Chem., 2019, 19(14), 1191-1200.
[2]
Vil’, V.A.; Terent’ev, A.O.; Mulina, O.M. bioactive natural and synthetic peroxides for the treatment of helminth and protozoan pathogens: Synthesis and properties. Curr. Top. Med. Chem., 2019, 19(14), 1201-1225.
[3]
Murthy, P.K. Strategies to control human lymphatic filarial infection: Tweaking host’s immune system. Curr. Top. Med. Chem., 2019, 19(14), 1226-1240.
[4]
Rando, D.G.G.; da Costa, M.O.L.; Pavani, T.F.A.; Oliveira, T.; dos Santos, P.F.; Amorim, C.R.; Pinto, P.L.S.; de Brito, M.G.; Silva, M.P.N.; Roquini, D.B.; de Moraes, J. Vanillin-related N-acylhydrazones: Synthesis, antischistosomal properties and target fishing studies. Curr. Top. Med. Chem., 2019, 19(14), 1241-1251.
Current Topics in Medicinal Chemistry
Title:Recent Advances in Medicinal Chemistry to Treat Filariasis and Helminthiasis
Volume: 19 Issue: 14
Author(s): Santosh K. Srivastava
Affiliation:
Export Options
About this article
Cite this article as:
Srivastava K. Santosh , Recent Advances in Medicinal Chemistry to Treat Filariasis and Helminthiasis, Current Topics in Medicinal Chemistry 2019; 19 (14) . https://dx.doi.org/10.2174/156802661914190828124745
DOI https://dx.doi.org/10.2174/156802661914190828124745 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
22
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives
Current Stem Cell Research & Therapy The Role of a Disturbed Arginine/NO Metabolism in the Onset of Cancer Cachexia: A Working Hypothesis
Current Medicinal Chemistry Introduction: Advancing Drug Discovery for Alzheimers Disease [ ISOA Fifth Annual Investigators Meeting “Recent Advances in Drug Discovery and Development for Alzheimers Disease” Sponsored by Elan Pharmaceuticals Inc, The Graphic Expression, Glaxo Smith Kline Pharmaceuticals, Neurochem Inc, Pfizer Inc. (Guest Editors: Howard M. Fillit and Lorenzo M. Refolo)]
Current Alzheimer Research Antimicrobial Drug Interactions in the Critically Ill Patients
Current Clinical Pharmacology Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture Mechanism of Action of Volatile Anesthetics: Involvement of Intracellular Calcium Signaling
Current Drug Targets - CNS & Neurological Disorders Meet Our Editorial Board Member
Current Neuropharmacology Dehydroevodiamine•HCl Protects Against Memory Impairment and Cerebral Amyloid-β Production in Tg2576 Mice by Acting as a β-Secretase Inhibitor
CNS & Neurological Disorders - Drug Targets Analytical Methods for the Measurement of Catechol-O-Methyltransferase Activity in Animal Tissues
Current Biotechnology At the “Junction” of Spinal Muscular Atrophy Pathogenesis: The Role of Neuromuscular Junction Dysfunction in SMA Disease Progression
Current Molecular Medicine Resistant TB: Newer Drugs and Community Approach
Recent Patents on Anti-Infective Drug Discovery Pour Point Depressant for Waxy Crude Oil: A Mini-Review
Recent Innovations in Chemical Engineering Motor Unit and Neuromuscular Junction Remodeling with Aging
Current Aging Science Approaching Clinical Reality: Markers for Monitoring Systemic Inflammation and Sepsis
Current Molecular Medicine Targeting the JNK Signaling Pathway for Stroke and Parkinsons Diseases Therapy
Current Drug Targets - CNS & Neurological Disorders Addressing Depression and Suicidality in the College Population
Current Psychopharmacology Defining the earliest pathological changes of Alzheimer’s disease
Current Alzheimer Research Radionuclide Imaging in Drug Development
Current Pharmaceutical Design Neuroinflammation, Microglia and Mast Cells in the Pathophysiology of Neurocognitive Disorders: A Review
CNS & Neurological Disorders - Drug Targets The Role of Probiotics and Prebiotics in Osteolastogenesis and Immune Relevance
Current Medicinal Chemistry